Earnings Preview: SNDX to Report Financial Results Post-market on May 05
NXP Semiconductors, Brinker International, Ultra Clean, Sanmina And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Why Leggett & Platt Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025
Barclays Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $19
Express News | Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum
Is Syndax Pharmaceuticals (NASDAQ:SNDX) A Risky Investment?
Syndax's Revuforj Earns Strong Physician Support, JP Morgan Predicts Sales Growth
J.P. Morgan Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Raises Target Price to $41
TD Cowen Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals Inc (SNDX) Q4 2024 Earnings Call Highlights: Strong Product Launch and ...
Positive Outlook on Syndax Pharmaceuticals: Strong Market Presence and Strategic Growth Initiatives
Syndax Pharmaceuticals Price Target Raised to $39.00/Share From $35.00 by JP Morgan
Syndax Pharmaceuticals Is Maintained at Buy by Citigroup
BTIG Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $43
Scotiabank Maintains Syndax Pharmaceuticals(SNDX.US) With Hold Rating, Maintains Target Price $16
Goldman Sachs Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $31
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $16 to $51